Amptiv Biosciences
Hudson
About Amptiv Biosciences
Amptiv Biosciences is a biotechnology company that focuses on advancing mRNA therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Pre-Seed (Dec 2024)
- Website: amptivbio.com
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/amptiv-biosciences-101368 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.